Santini, V., Komrokji, R. S., Savona, M. R., Díez-Campelo, M., Fenaux, P., Sekeres, M. A., Madanat, Y. F., Valcárcel, D., Jonášová, A., Belohlavkova, P., Berry, T., Dougherty, S., Shah, S., Xia, Q., Sun, L., Wan, Y., Huang, F., Feller, F., Navada, S., Zeidan, A. M. and Platzbecker, U. (2020) “Overall survival and long-term outcomes from the randomized, double-blind, placebo-controlled, phase III IMerge trial of imetelstat for lower-risk myelodysplastic syndromes”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301456.